Bolt Biotherapeutics Ownership | Who Owns Bolt Biotherapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Bolt Biotherapeutics Ownership Summary

Bolt Biotherapeutics is owned by 49.10% institutional investors, 3.46% insiders, and 47.44% retail investors. Tang capital management is the largest institutional shareholder, holding 10.02% of BOLT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.25% of its assets in Bolt Biotherapeutics shares.

BOLT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Bolt Biotherapeutics	49.10%	3.46%	47.44%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Tang capital management	3.81M	10.02%	$2.86M
Vivo capital	3.52M	9.25%	$2.64M
Sofinnova investments	2.75M	7.24%	$2.07M
Citadel advisors	2.37M	6.22%	$1.78M
Pivotal bioventure partners investment advisor	1.89M	4.97%	$1.42M
Newtyn management	1.36M	3.58%	$1.02M
Nan fung group	1.17M	3.07%	$875.21K
Vanguard group	1.07M	2.80%	$800.55K
Samsara biocapital	1.05M	2.76%	$786.87K
Board of trustees of the leland stanford junior university	719.55K	1.89%	$539.66K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Pivotal bioventure partners investment advisor	1.89M	1.09%	$1.42M
Nan fung group	1.17M	0.93%	$875.21K
Tang capital management	3.81M	0.29%	$2.86M
Vivo capital	3.52M	0.24%	$2.64M
Newtyn management	1.36M	0.19%	$1.02M
Samsara biocapital	1.05M	0.16%	$786.87K
Sofinnova investments	2.75M	0.11%	$2.07M
Board of trustees of the leland stanford junior university	719.55K	0.04%	$539.66K
Adar1 capital management	186.00K	0.03%	$139.50K
Bridgeway capital management	85.20K	0.00%	$63.90K

Top Buyers

Holder	Shares	% Assets	Change
Tang capital management	3.81M	0.29%	392.77K
Adar1 capital management	186.00K	0.03%	181.00K
Jane street group	41.53K	-	41.53K
Ubs group	48.83K	-	36.65K
Assenagon asset management	34.49K	0.00%	34.49K

Top Sellers

Holder	Shares	% Assets	Change
Orbimed advisors	-	-	-1.54M
Acuitas investments	-	-	-630.51K
Newtyn management	1.36M	0.19%	-336.77K
Renaissance	276.74K	0.00%	-240.90K
Marquette asset management	-	-	-113.80K

New Positions

Holder	Shares	% Assets	Change	Value
Assenagon asset management	34.49K	0.00%	34.49K	$25.87K
Susquehanna group, llp	22.41K	-	22.41K	$16.81K

Sold Out

Holder	Change
Qube research	-2.00
Wells fargo & company/mn	-211.00
Steward partners investment advisory	-1.00K
Virtu financial	-10.94K
Xtx topco	-12.83K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	31	-11.43%	18,782,187	-16.99%	49	1.39%	10	-37.50%	8	33.33%
Jun 30, 2024	35	-5.41%	22,625,732	-5.73%	59	1.48%	16	60.00%	6	-45.45%
Mar 31, 2024	37	-2.63%	24,001,384	-0.52%	63	1.56%	10	-33.33%	11	-8.33%
Dec 31, 2023	38	15.15%	24,125,809	-1.70%	63	1.51%	15	50.00%	12	50.00%
Sep 30, 2023	33	-17.50%	24,542,560	-2.54%	65	1.46%	10	-28.57%	8	-11.11%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	861.87K	2.25%	-
Vanguard Institutional Extnd Mkt Idx Tr	205.54K	0.54%	-
Fidelity Extended Market Index	149.94K	0.39%	-606.00
Fidelity Total Market Index	108.27K	0.28%	-18.68K
Fidelity Enhanced Small Cap ETF	82.00K	0.21%	-572.00
iShares Micro-Cap ETF	70.16K	0.18%	-
Bridgeway Ultra-Small Company Market	60.20K	0.16%	-25.00K
Fidelity Series Total Market Index	29.67K	0.08%	-
Fidelity VIP Disciplined Small Cap Init	27.70K	0.07%	-
NT Ext Equity Mkt Idx Fd - L	25.89K	0.07%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 12, 2023	Quinn William P.	Chief Financial Officer	Buy	$7.13K
Jun 06, 2023	Quinn William P.	Chief Financial Officer	Buy	$2.16K
Dec 06, 2023	Quinn William P.	Chief Financial Officer	Buy	$1.96K
Nov 30, 2023	ENGLEMAN EDGAR	-	Sell	$92.80K
Nov 29, 2023	ENGLEMAN EDGAR	-	Sell	$20.54K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	2	24
2023 Q2	1	-

BOLT Ownership FAQ

Who Owns Bolt Biotherapeutics?

Bolt Biotherapeutics shareholders are primarily institutional investors at 49.10%, followed by 3.46% insiders and 47.44% retail investors. The average institutional ownership in Bolt Biotherapeutics's industry, Biotech Stocks , is 47.04%, which Bolt Biotherapeutics exceeds.

Who owns the most shares of Bolt Biotherapeutics?

Bolt Biotherapeutics’s largest shareholders are Tang capital management (3.81M shares, 10.02%), Vivo capital (3.52M shares, 9.25%), and Sofinnova investments (2.75M shares, 7.24%). Together, they hold 26.50% of Bolt Biotherapeutics’s total shares outstanding.

Does Blackrock own Bolt Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of Bolt Biotherapeutics.

Who is Bolt Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Pivotal bioventure partners investment advisor is Bolt Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 1.09% of its assets in 1.89M Bolt Biotherapeutics shares, valued at 1.42M$.

Who is the top mutual fund holder of Bolt Biotherapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Bolt Biotherapeutics shares, with 2.25% of its total shares outstanding invested in 861.87K Bolt Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools